The upregulation of the P62 pathway may represent a compensatory mechanism for defective mitophagy, making compounds related to PMI potential tools to restore mitophagy in pathological conditions in which the PINK1/Parkin pathway is impaired such as in Parkinson disease (Chu, 2010, Narendra et al., 2009). This evidence concerns the gene SQSTM1 and Parkinson disease.